83 related articles for article (PubMed ID: 18852930)
1. Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
Hellwig D; Gouverneur E; Schaefer A; Raedle J; Menges M; Kirsch CM; Samnick S
Nuklearmedizin; 2008; 47(5):220-4. PubMed ID: 18852930
[TBL] [Abstract][Full Text] [Related]
2. p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
Samnick S; Romeike BF; Kubuschok B; Hellwig D; Amon M; Feiden W; Menger MD; Kirsch CM
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):532-41. PubMed ID: 14722685
[TBL] [Abstract][Full Text] [Related]
3. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
[TBL] [Abstract][Full Text] [Related]
4. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
[TBL] [Abstract][Full Text] [Related]
5. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
6. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
[TBL] [Abstract][Full Text] [Related]
7. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
Bauwens M; Keyaerts M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
Nucl Med Commun; 2007 Oct; 28(10):823-8. PubMed ID: 17728613
[TBL] [Abstract][Full Text] [Related]
9. Systemic Endoradiotherapy with Carrier-Added 4-[(131)I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory Glioma.
Baum RP; Kluge A; Gildehaus FJ; Bronzel M; Schmidt K; Schuchardt C; Senftleben S; Samnick S
Nucl Med Mol Imaging; 2011 Dec; 45(4):299-307. PubMed ID: 24900021
[TBL] [Abstract][Full Text] [Related]
10. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
[TBL] [Abstract][Full Text] [Related]
11. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
12. Validation of brain tumour imaging with p-[123I]iodo-L-phenylalanine and SPECT.
Hellwig D; Ketter R; Romeike BF; Sell N; Schaefer A; Moringlane JR; Kirsch CM; Samnick S
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1041-9. PubMed ID: 15902439
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G
J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
[TBL] [Abstract][Full Text] [Related]
16. 123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):919-27. PubMed ID: 16572305
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor.
Versijpt J; Dumont F; Thierens H; Jansen H; De Vos F; Slegers G; Santens P; Dierckx RA; Korf J
Eur J Nucl Med; 2000 Sep; 27(9):1326-33. PubMed ID: 11007514
[TBL] [Abstract][Full Text] [Related]
18. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide receptor scintigraphy.
Virgolini I; Kurtaran A; Raderer M; Leimer M; Angelberger P; Havlik E; Li S; Scheithauer W; Niederle B; Valent P
J Nucl Med; 1995 Oct; 36(10):1732-9. PubMed ID: 7562036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
